Sabine Topka

Director of Discovery Biology at Rarebase
  • Claim this Profile
Contact Information
Location
Mountain View, California, United States, US
Languages
  • English Professional working proficiency
  • German Native or bilingual proficiency
  • Italian Limited working proficiency

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Credentials

  • Good Clinical Practice (GCP)
    CITI Program
    Nov, 2021
    - Sep, 2024
  • Human Subjects Protection (HSP) Group 1: Biomedical Research
    CITI Program
    Nov, 2021
    - Sep, 2024
  • Schrödinger's "Introduction to Molecular Modeling in Drug Discovery"
    Schrödinger

Experience

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Director of Discovery Biology
      • Jan 2022 - Present
    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Senior Research Scientist
      • Apr 2021 - Jan 2022

    • Postdoctoral Research Associate
      • Jul 2017 - Apr 2021

      Human genetics research aimed at expanding our knowledge on how certain inherited genetic variants can contribute to the development of a broad range of cancers. Functional analysis of germline variants in DNA repair genes, specifically genes involved in double strand break repair and nucleotide excision repair. Use of cellular model systems and assays to examine the biological consequences genetic variants on protein function and cellular pathways as well as xenograft models to determine drug responses in certain mutational backgrounds. o Identification and evaluation of genetic biomarkers of drug response, preclinical proof-of-concept studies o CRISPR/Cas9 genome editing, specifically precise editing of single nucleotidechanges with application of cutting edge variant detection methods (ddPCR, CRISPR‐seq)o Induced pluripotent stem cell (iPSC) culture, transfection, genome editing,differentiation of iPSCs and re‐programming of patient fibroblast cells into iPSCs Show less

    • Postdoctoral Research Fellow
      • Apr 2014 - Jun 2017

      • Setting up wet lab for functional genomics studies • Established methodologies and protocols for experimental genomics research• Functional characterization of genetic variants related to leukemia and breast cancer predisposition

    • Associate Laboratory Director and Head of Functional Genomics
      • Nov 2019 - Jan 2022

      The focus of my work in this role was to identify genetic biomarkers predictive of drug response and to define which patients would benefit most from such targeted therapeutic interventions. To this end, we leveraged information from large next-generation sequencing datasets identifying genetic alterations associated with cancer risk and used CRISPR/Cas9 technology to precisely model these changes. Using these models we were able to analyze the functional consequences of these genetic variants in vitro and in vivo. Show less

Education

  • The University of Bonn
    Doctor of Philosophy (Ph.D.), Biology, General
    2008 - 2014

Community

You need to have a working account to view this content. Click here to join now